Compare SPDR Gold Trust (GLD) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs Intuitive Surgical, Inc. — how do they compare? SPDR Gold Trust trades at $384.58 (market cap $139.66B), while Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B). The key difference: SPDR Gold Trust and Intuitive Surgical, Inc. are close in size by market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Intuitive Surgical, Inc. for 84 Days on average.
| GLD | ISRG | |
|---|---|---|
Market Cap | $139.66B | $146.76B |
Volume | 9,544,773 | 2,529,814 |
52-Week High | $495.90 | $592.85 |
52-Week Low | $362.32 | $332.02 |
Typical Hold Time | 74 Days | 84 Days |
Sector | — | Health |
Enterprise Value | — | $141.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD, the SPDR Gold Trust ETF, is trading at $378.67 with a modest 0.74% daily gain amid ongoing pressure from rising Treasury yields and Federal Reserve policy uncertainty. Technical indicators show a bearish bias with 17 sell signals versus 2 buy signals, while fundamental analysis is limited for this commodity-based ETF. Recent news highlights gold's struggle to maintain momentum despite safe-haven demand, with prices testing key support levels as bond market dynamics dominate the narrative.
The outlook for GLD remains challenged by persistent rate hike expectations and dollar strength, though strategic allocations to gold as a portfolio diversifier continue to be recommended. Key risks include further yield increases and potential break below $4,000 support, while opportunities exist for tactical positions if Fed policy becomes more dovish or geopolitical tensions escalate.
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.
ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
